The proposed 9-gene signature contains genes related to T cell activation, cytotoxicity, and the regulation of IFN-γ downstream, which may indicate that this signature can affect CD8+ T cells through IFN-γ activation in melanoma. The gene discussed is CD8A; the disease is melanoma.